LOGO LOGO
Stock Code 603707.SH
  • ABOUT
    >
    Company profile Enterprise Culture Early Warning System
  • BUSINESS
    >
    Commercialized Products
  • MEDIA
    >
    News in NKF
  • CONTACT
CH / EN
Home  >  MEDIA > News in NKF > King-Friend will meet you in CPHI Frankfurt!
2025-05-19

King-Friend will meet you in CPHI Frankfurt!

share
Return

Previous NKF's Cyanocobalamin Injection gets FDA approval for marketing Next Paclitaxel For Injection (Albumin Bound) approved by US FDA

Relevant recommendations

  • 2025-05-26
    NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
  • 2025-05-22
    NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
  • 2025-05-20
    Paclitaxel For Injection (Albumin Bound) approved by US FDA
  • 2025-05-13
    King-Friend will meet you in CPHI Shanghai!
  • 2025-04-04
    NKF's Liraglutide Injection gets FDA approval for marketing
  • ABOUT
  • BUSINESS
  • MEDIA
  • CONTACT
Stock price
11.540
-0.47
©2025 Nanjing King-Friend Biochemical Pharmaceutical Co.LtdSu ICP Bei No. 13012010
  • Disclaimers
  • Privacy policy
  • Site map